1 2009 annual report 10th Anniversary Edition
2 organisation chart key achievements Board Mr Bill Manning Chairman Director Winthrop Professor Philip Thompson Executive Officer Ms Tineke Van der Eecken Celebration of our 10th Anniversary. Breathe Easy lung awareness week. Lung and Biological Sciences Symposium. Biological Sciences CLINICAL Sciences CORPORATE SERVICES Establishment of new professorial post. Expanded organisational structure. Formation of community support group, LIFE. Tissue Repair Associate Professor Steven Mutsaers Clinical Trials Ms Michelle Davies Respirology Dr Lieve Bultynck Receipt of major grants. Continued support for careers of scientists and students. Inflammation / Immunology / Cancer Professor Kanti Bhoola Pulmonary vascular and Advanced lung disease Associate Professor Eli Gabbay Administration & Finance Ms Tineke Van der Eecken Molecular Genetics Winthrop Professor Philip Thompson Physiotherapy Associate Professor Sue Jenkins Public Relations Ms Sharon Squires-Hansen MAKING A DIFFERENCE Pleural Disease Winthrop Professor Gary Lee Infectious Diseases Professor Grant Waterer Community Support LIFE Mrs Edna Brown Ms Jenni Ibrahim Cardiothoracic Surgery Research Mr Mark Newman CF/Bronchiectasis Research Dr Siobhain Mulrennan Annual Report Lung Institute of Western Australia Inc.
3 contents 4 About LIWA 6 8 Chairman s Report 9 13 Director s Report Board Members 18 Scientific Subcommittee Report Education Programs and Initiatives th Anniversary Celebrations LIWA in the Community Unit Report 26 Biological Sciences Tissue Repair Inflammation / Immunology / Cancer Molecular Genetics Pleural Disease Unit 36 Clinical Sciences 36 Clinical Trials Unit Pulmonary Vascular and Advanced Lung Disease Physiotherapy Infectious Diseases Cardiothoracic Surgery 44 Cystic Fibrosis / Bronchiectasis 45 Corporate Services 45 Respirology 46 Community Support Group, LIFE 47 Administration / Finance 48 Public Relations 49 Active LIWA Partnerships and Alliances 50 Donations and Sponsorships Publications Report 57 Grants Report Financial Report 3
4 ABOUT LIWA our aims The aims of LIWA are to: Support high quality research into the treatment and management of lung diseases including asthma, chronic bronchitis, emphysema, bronchiectasis, cystic fibrosis, pulmonary vascular diseases, lung cancer, pneumonia and tuberculosis. Support research into associated conditions. Improve the well-being of patients. Support the careers of young scientists. Provide a strong educational and scientific resource for the community at large, and Be an advocacy group for better lung health. our activities Clinical sciences respiratory research, including the Clinical Trials Unit. Biological sciences respiratory research. Education initiatives. Awards and scholarships. Membership (Medical / Scientific; Student; Community; Corporate). Community awareness, advocacy and support activities. Patient support activities. Collaborations with leading clinical and research institutes around the world, and Editorial office of Respirology. about LIWA The Lung Institute of Western Australia (LIWA) is a charitable organisation dedicated to the investigation and treatment of lung disease. As one of only two institutes in Australia with this focus, LIWA prides itself on world-class laboratory science, clinical research and clinical practice with the purpose of making a difference to those with lung disease. Our philosophy is that everyone who comes into contact with the Institute should be better informed and healthier for the experience. Objectives The objectives of LIWA are to: Establish and maintain a centre of excellence for research into all aspects of lung disease that will: conduct laboratory, clinical and epidemiological research into the cause, diagnosis, prevention and treatment of lung diseases. support doctors, scientists, students and other individuals to pursue research careers in lung disease and related disorders. foster international and national networks for research into lung disease Annual Report Lung Institute of Western Australia Inc.
5 Promote prevention and best practice in lung diseases by providing community and professional education. Be a source of expert knowledge in relation to lung diseases for health professionals, government, community groups and individuals. Provide leadership in the management and prevention of lung and related disorders. Be a source of clinical advice to patients with lung disease. Be an advocate for patients with respect to lung diseases. Reduce the prevalence of cigarette smoking in the community, and Raise funds to support research and education in lung diseases and related disorders. Background and inspiration to LIWA Lung disease is a common, disabling issue which requires ongoing commitment to the investigation of its causes, treatment and cure. Diseases such as asthma, COPD (chronic obstructive pulmonary disease such as emphysema and chronic bronchitis), pneumonia, lung cancer, pulmonary hypertension, cystic fibrosis and bronchiectasis cause significant disability to individuals as well as placing a large burden on the health system. With one in four families affected by lung disease, research into this group of diseases is a priority for government, health organisations and research bodies around the globe. LIWA s approach to respiratory disease is to integrate scientific research and clinical practice. As a result, many diseases are being addressed and investigated utilising the very best of laboratory and clinical sciences and clinical trials. LIWA s history LIWA was founded as the Asthma and Allergy Research Institute (AARI) in February 1998 by Professor Philip Thompson. Professor Thompson is one of Australia s leading respiratory clinicians who is well recognised for his achievements in research and clinical respiratory medicine. In 2006 the Institute changed its name to the Lung Institute of Western Australia to reflect the broadening scope of its activities. LIWA is administratively based at Sir Charles Gairdner Hospital in Nedlands (SCGH), Western Australia and has operations at Royal Perth Hospital as well as strong affiliations with the University of Western Australia (UWA) and Curtin University. The Institute is committed to strengthening partnerships and affiliations with other academic and respiratory organisations for the benefit of improving the respiratory health of the community. ABOUT LIWA 5
6 ABOUT LIWA CHAIRMAN S REPORT chairman s report Bill Manning Chairman I am pleased to present the report of the Board of the Lung Institute of Western Australia for the Institute s tenth year of operation, being 1 January to 31 December The Board met on nine occasions during these 12 months. The Board welcomed new members Bill Coleman and Jesper Sentow. Each brings a wealth of experience to add to the Board s expertise. Rachael Offer succeeded Feliciano Sanchez as Cystic Fibrosis WA Representative, and Gary Lee stood in as a UWA representative during Grant Waterer s sabbatical leave. I would like to extend my gratitude to Feliciano Sanchez for his significant contribution as a Board member and for his continued support to LIWA as President of CFWA. I thank the Board members as a whole for taking the time, away from other work as well as family commitments, to assist the Institute in achieving its objectives. 10th Anniversary Celebrations In 2009 the Board endorsed proposals to celebrate the 10th Anniversary of the Institute. This kicked off with a world-class Lung and Biological Sciences Symposium, with presenters from our own ranks among scientists from Berlin, Hong Kong, Beijing and other reputable Australian research institutes. The inaugural Breathe Easy Week was another great initiative and served to raise awareness of lung health in the community. The Board was impressed with the quality and results of the many events held promoting lung health in the wider community and was grateful for the efforts of LIWA staff and supporters. Strategic Directions The Board has identified the following priority areas: Finding a single geographical location to house LIWA; Recruiting senior staff with a superior track record to join LIWA; Embracing and enhancing the role of members; and Developing sustainable resources. Each of these priorities continue to guide initiatives by Institute staff. With regards to a single location, LIWA has been offered accommodation in the new WAIMR research facility on the SCGH grounds. Building is due to start later this year. Professor Gary Lee joined LIWA in 2009 as a world leader in pleural disease research and the Institute is looking at ways to attract more senior academic staff in respiratory health to Western Australia. Board members had the opportunity to take part in an Open Space type meeting which brought together all Annual Report Lung Institute of Western Australia Inc.
7 LIWA staff and interested Board members to think about how to take LIWA to the next decade of excellence. This generated useful inputs into our strategic planning, which I see as an ongoing process. Policy Development The Board adopted a new Conflict of Interest policy. Policies on more operational matters were referred to the Executive Officer and Management Committee to develop. It is worth noting that input from individual Board members was provided for the development of new standard contracts for clinical trials, for advice on insurance issues, and for the development of new staff contracts. Affiliations Affiliations with universities and other leading organisations in Western Australia have enhanced the Institute s capacity in many different ways. University of Western Australia Our affiliation with UWA continues to be a close and supportive relationship. In 2009, UWA publicly demonstrated its support with the Vice Chancellor, Professor Alan Robson, officially launching LIWA s Lung and Biological Sciences Symposium. The UWA renewed the UWA Centre for Asthma and Allergy Respiratory Research (CAARR). This Centre is managed by LIWA staff with the successful Photo: Free lung testing during Breathe Easy Week representation of senior UWA staff on the Board including Emeritus Professor Lou Landau, Professor Grant Waterer and Winthrop Professor Gary Lee, which is of great benefit to the Institute. I am also pleased to say that this collaboration works on many levels and in day-to-day activities, including involvement in research projects and LIWA sponsorship of scholarships and awards. Cystic Fibrosis Western Australia (CFWA) The affiliation with CFWA continued to strengthen in 2009, with Board representation being provided by Feliciano Sanchez, followed by Rachael Offer. The CFWA Board supported the inaugural Breathe Easy Week lung awareness week initiated by LIWA. In addition, the respective Boards met to discuss the potential establishment of a new professorial position for cystic fibrosis and infectious respiratory disease in Perth. Westcare Westcare and LIWA provide mutual support on an organisational level through reciprocal board membership. Sue Morey represents Westcare on the Board of LIWA. In 2009, Westcare reiterated its desire to support tuberculosis and infectious lung disease research in Western Australia and the two organisations discussed how LIWA could play a future role in managing a dedicated fund towards such research. ABOUT LIWA CHAIRMAN S REPORT 7
8 Australian Society of Clinical Immunology and Allergy (ASCIA) John Bandouvakis continued to informally represent ASCIA on the Board. Western Australian Institute of Medical Research LIWA s affiliation with WAIMR remained robust in 2009, with the prospect of LIWA being housed in the WAIMR managed research facility soon to be built at the QEII Medical Centre campus. Curtin University Our affiliation with Curtin University enables ongoing research, in particular through our Physiotherapy Unit. The agreement with Curtin University also allows LIWA to offer Curtin University students the opportunity of applying for LIWA scholarships and awards. I would like to thank the staff and the members of the Board for taking the Institute to the next level, and look forward to further growth and development in 2010, and indeed, over the Institute s next 10 years of activity. ABOUT LIWA CHAIRMAN S REPORT Bill Manning Chairman Annual Report Lung Institute of Western Australia Inc.
9 director s report 2009 was a year of achievement and celebration befitting our 10th Anniversary. LIWA continued to demonstrate its commitment to improving respiratory health and worked diligently to meet its objectives this year. Expanding our Organisational Structure The organisational structure of LIWA has continued to develop, with significant new initiatives to demonstrate our broadened scope of research. Three new research units were established in 2009, including the Pleural Disease Unit, the Cystic Fibrosis and Bronchiectasis Unit and the Cardiothoracic Surgery Unit. Each of these units has attracted leading clinicians and scientists to join forces with LIWA to tackle important areas of lung disease. The establishment resulted in new collaborations being made with other organisations. Other units continued to excel in the quality of research conducted, being awarded with significant grants and gaining international recognition. The Institute was also pleased to welcome LISA (Lung Impaired Support Association), a community support group, to the Institute. Now known as LIFE (Lung Information and Friendship for Everyone), this well-established group brings to LIWA much experience and understanding of supporting people living with lung disease in the community. The revised administrative staffing structure which was put into place at the end of 2008 has proved highly effective. Our new Executive Officer, Tineke Van der Eecken, brought much experience and drive to the organisation, as did Public Relations Manager, Sharon Squires-Hansen and Robyn Tandon as Memberships and PR Officer. The appointment of Finance Officer, Bi Lam, and Human Resource person Karen Coveney also resulted in significant improvements in the financial and human resource administration. Research and Collaborations LIWA s scientists continued to excel in research in collaboration with research organisations and institutes from around the world, including countries such as Japan, USA, UK, Chile, South Africa, Germany, Singapore and the Netherlands as well as local and interstate universities. New research grants were secured and significant research advances achieved. ABOUT LIWA DIRECTOR S REPORT 9
10 ABOUT LIWA DIRECTOR S REPORT Outstanding Educational Opportunities LIWA s 10th Anniversary year began with a world-class Lung and Biological Sciences Symposium, a free two day meeting held at the University Club at the University of Western Australia. LIWA attracted local, national and international delegates and speakers. The Symposium covered an innovative program with topics crossing the traditional boundaries between clinical and biological sciences and offered new insights into many areas of lung disease. The Institute s monthly Medical Research Seminar Series continued to be a popular event for clinicians and scientists. The diversity of material covered in this series demonstrates LIWA s commitment to supporting research and activities in a range of fields, from scientific imaging, to tobacco control legislation. LIWA also celebrated its 10th Anniversary by expanding its awards and scholarship opportunities to a new level. In addition to PhD Top Up scholarships, Travel Awards and Vacation Cadetships, LIWA was pleased to demonstrate its support for younger scientists, including Bachelor of Medical Science students, by introducing two new $5000 scholarships for honours students. Clinical Trials Achievements The Clinical Trials Unit continues to demonstrate its leadership in the field of clinical respiratory research within Australia, with 14 trials being conducted in These trials involved conditions such as asthma, emphysema, bronchiectasis, chronic bronchitis and influenza. New trial areas this year included cystic fibrosis and alpha 1-antitrypsin deficiency. Organisational Process Initiatives In an effort to continually improve standards, new processes were introduced and existing procedures reviewed. A significant development was the successful introduction of substantive performance review structure, which will continue to maintain and improve productivity and staff development. The Management Committee reviewed or developed policies on HR, including recruitment and selection, conference travel, and a code of ethics. Considerable investments were made to update our computer network and IT structure and adopt appropriate policies. Another significant event in terms of organisation management was the use of an Open Space type meeting which brought together all LIWA staff and interested Board members to think about how to take LIWA to the next decade of excellence. The meeting generated 13 agenda items and as many conversations, which were brought together in a Book of Proceedings Annual Report Lung Institute of Western Australia Inc.
11 LIWA in the Community As a lead respiratory organisation in Western Australia, we are aware of the need for a unified message on lung health to reach the community. In 2009 the inaugural Breathe Easy Week was launched. This lung awareness week initiated by LIWA was supported by respiratory organisations in Western Australia such as Cystic Fibrosis WA, the Asthma Foundation of WA and the Australian Lung Foundation. The success of this event in raising awareness in the community encourages us to ensure this becomes a well-established event in the Western Australian community calendar. The establishment of our community self help group, LIFE, was a major milestone for the Institute and significantly the official launch was supported by the Health Minister the Honorable Kim Hames. LIFE is already assisting us to achieve our aim of providing support to people affected by lung disease, by encouraging self help for its members and others associated with this group. LIFE also enables community members to access information regarding respiratory issues through newsletters and regular presentations. LIWA is proud to involve the community through its membership program which allows people to remain connected with the Institute and its activities. Members receive a range of benefits including newsletters and access to educational and social events. We value our members greatly and look forward to seeing our membership base grow. Another important event was commissioning a history of LIWA s first ten years. Vannessa Hawthorn kindly took on the role of interviewing past and present staff, members and patients, and writing the story which we hope to publish in the near future. I would like to sincerely thank all staff involved with LIWA for their outstanding efforts in Their commitment, dedication and talent has enabled LIWA to once again achieve an outstanding performance of which we are all proud. Finally I would like to express my sincere gratitude to the Board. The generosity of their time and wisdom is fundamental to our success and wellbeing and is much appreciated. Winthrop Professor Philip Thompson Director ABOUT LIWA DIRECTOR S REPORT 11
12 ABOUT LIWA DIRECTOR S REPORT Director s Activities Positions held Director, Lung Institute of Western Australia. President, Thoracic Society of Australia and New Zealand. Winthrop Professor, School of Medicine and Pharmacology, University of Western Australia. Director, Centre for Asthma, Allergy and Respiratory Research, UWA. Clinical Professor, Division of Health Sciences, Curtin University. Director, CRC for Asthma and Airways Western Australian Node. Co-Director, National Health and Medical Research Council Centre of Clinical Research Excellence. Consultant Respiratory Physician, Sir Charles Gairdner Hospital. Member, Board of the Cystic Fibrosis Association of WA. Member, Board of Westcare Industries Pty Ltd. Member, Editorial Board, Respirology. Editor-in-Chief, Respirology (till April 09). UWA Vice-Chancellor Professor Alan Robson with Professor Philip Thompson, WA Chief Scientist Professor Lyn Beazley and Mr Max Kay Committee Memberships Founding member, International Medical Communications Association. Member, Asian Pacific Society of Respirology. Member, Australasian Society of Clinical Immunology and Allergy. Member, International Association for Allergy and Clinical Immunology. Fellow of the Academy of American Chest Physicians. Member, European Respiratory Society. Member, Thoracic Society of Australia and New Zealand. Member, American Thoracic Society. Member, Committee of Publishing Ethics UK. Other Activities Professor Thompson has acted as referee for the following scientific journals: American Journal of Respiratory and Critical Care Medicine; Chest; Clinical and Experimental Allergy, and Pharmacogenetics and Genomics. Professor Thompson has acted as referee for the following granting bodies: National Health and Medical Research Council; Health Research Council of New Zealand, and the Asthma and Respiratory Foundation of New Zealand Annual Report Lung Institute of Western Australia Inc.
13 Postgraduate Students Dr Li Ping Chung PhD Ms Faang Cheah PhD Ms Hui Ling Lau PhD Ms Sally Lansley PhD (awarded) Ms Svetlana Baltic PhD (awarded) Ms Sian Turner PhD (awarded) Ms Melanie Dunn Honours Publications In journal articles were published. For more details, see the Publications Report. Grants Professor Thompson received funding from six grants in the 2009 period. For more details, see the Grants Report. ABOUT LIWA DIRECTOR S REPORT 13
14 board members Mr William Manning BA LLB (Qld) Chairman Mr Bill Manning holds the degrees of Bachelor of Arts and Bachelor of Law from the University of Queensland. He is admitted as a solicitor in Western Australia, Queensland, New South Wales, Victoria, England and Wales and Hong Kong and has practised in the areas of natural resources law and commercial law for the last 40 years. ABOUT LIWA BOARD MEMBERS Annual Report Lung Institute of Western Australia Inc. Winthrop Professor Philip Thompson MBBS FRACP FCCP MRACMA Director Professor Philip Thompson is Winthrop Professor of Respiratory Medicine at the University of Western Australia, an Adjunct Professor at Curtin University and a Consultant Respiratory Physician at Sir Charles Gairdner Hospital. He is the President of the Thoracic Society of Australia and New Zealand, immediate past Editor-in-Chief of Respirology, Director of the WA Node of the CRC for Asthma and Airways and a member of the Boards of Westcare and Cystic Fibrosis WA. He has been involved in asthma and airways research and care for respiratory patients for more than 28 years, and is recognised internationally for his work on airway pharmacology, house dust mite allergy and for his involvement in asthma therapeutics. Professor Thompson has over 240 medical and scientific publications.
15 Professor Lou Landau AO MBBS MD FRACP Deputy Chair Professor Landau is Emeritus Professor of Paediatrics, UWA and Chair of the Postgraduate Medical Council of Western Australia. He was Dean of the Faculty of Medicine and Dentistry from 1996 to A graduate of the University of Melbourne, Professor Landau was appointed to the Chair in Paediatrics at UWA in He was a Board member and Chairman of the Telethon Institute for Child Health Research and the Western Australian Institute for Medical Research. He received the Order of Australia in 1996 and a Centenary Medal in His varied research interests include the natural history of childhood asthma, infant lung function measurement and models of medical education. He has over 250 publications in scientific journals. Professor Michael Garlepp BSc (Hons) PhD MPS Secretary Professor Garlepp was Associate Director at the Telethon Institute of Child Health Research until the end of 2009 having previously been Professor of Pharmaceutical Biology and Head of the School of Pharmacy at Curtin University. He is a Pharmacy graduate from Curtin University and has a PhD in immunology from UWA. Postdoctoral research in Calgary, Canada, and London, UK, was followed by research appointments in the Department of Medicine UWA and at the Australian Neuromuscular Research Institute. Research interests include genetics and mechanisms of autoimmune disease, genetics and gene therapy of mesothelioma, and genetics of neurological diseases. He will continue as a half-time academic during Mr Stephen Hughes BBus ANZIIF (Fellow) LLB Dip Treasurer Mr Hughes is a general insurance broker who specialises in professional indemnity, directors and officers liability and clinical trials insurance for companies around Australia, and internationally. Stephen actively consults and provides risk management advice to directors, professionals, and corporate entities including research organisations. Prior to becoming an insurance broker Stephen was the Western Australian manager for the professional and financial services division of Royal and Sun Alliance Insurance company. Ms Sue Morey OAM FRCNA Westcare representative Ms Morey joined as a Board Member in 2007 as the Westcare representative, following our new alliance with the organisation. She has spent the last 35 years as a nurse in the Department of Respiratory medicine. In 2007 Sue completed a postgraduate degree enabling her to register and practise as a nurse practitioner in respiratory medicine. Sue has seen many changes in respiratory medicine from pulmonary TB, asbestos related diseases, better management of asthma, cystic fibrosis, and the development of lung transplantation and interventional endobronchial procedures. ABOUT LIWA BOARD MEMBERS 15
16 ABOUT LIWA BOARD MEMBERS 16 Mr James Baker BEng Dip Mr Baker is a practising Electronics Engineer. He has worked extensively as a consultant and development engineer from the Middle East to Far East Asia. He is director of his own company and is also currently the Principal SCADA Engineer with the Water Corporation of Western Australia. Dr John Bandouvakis MBBS (Hons) MRACP FRACP Dr Bandouvakis joined as a Board Member in July 2007 as the ASCIA representative. He undertook specialist training in Respiratory Medicine at Concord Hospital, Sydney and continued at Sir Charles Gairdner Hospital, after moving to Perth in Dr Bandouvaskis then worked as a research fellow at McMaster University, Canada in 1979 to 1980, obtaining further training in allergy/clinical immunology, as well as undertaking clinical research in allergic asthma and some types of occupational asthma. He returned to Perth in 1981 and commenced private practice in Allergy and Respiratory Disease Annual Report Lung Institute of Western Australia Inc. Mr Bill Coleman AM BSocSc BJuris LLB Mr Bill Coleman was elected to the LIWA Board in January Bill holds a Bachelor of Social Sciences and a Bachelor of Jurisprudence. He retired as Chief Commissioner of the WA Industrial Relations Commission in 2004 after 20 years. Prior to this, he was secretary of the Australian Medical Association of Western Australia (AMAWA). Presently, Bill holds the position of Chairman of the Salaries and Allowances tribunal of Western Australia. He has held Board positions with other charitable organisations in Western Australia, including Diabetes WA and the Diabetes Research Foundation of WA. Winthrop Professor Gary YC Lee MB ChhB (NZ) PhD FCCP FRACP UWA Representative Professor Gary Lee is a clinician scientist renowned for translational research in pleural diseases. He is Winthrop Professor of Respiratory Medicine at the University of Western Australia, a consultant chest physician and Head of Pleural Services at Sir Charles Gairdner Hospital, Editor-in-Chief of the journal Respirology, co-editor of the International Pleural Newsletter and Head of the Pleural Disease Unit of LIWA. He has published over 100 original and invited papers and two books. He is a regular invited speaker at major international respiratory conferences and has lectured in 19 countries on topics covering both basic and clinical science of pleural diseases. He is a member of the British Thoracic Society Pleural Disease guidelines working group. Gary is the UWA representative on the LIWA Board (Aug-Dec 2009).
17 Ms Rachael Offer BJuris LLB BA(Eng) CFWA representative Ms Offer holds a Bachelor of Laws, a Bachelor of Jurisprudence and a Bachelor of Arts (Eng). She is currently employed by the Western Australian Land Information Authority, Landgate, as the legal counsel on Landgate s National Electronic Conveyancing System Project. She is a member of the Law Society of Western Australia and the Australian Corporate Lawyers Association. Before joining Landgate, Rachael was employed at national law firm Corrs Chambers Westgarth, practising in the Commercial Division in the areas of property, banking & finance and Local Government. Rachael has been a member of the Committee of Management of Cystic Fibrosis Association of Western Australia Incorporated (CFWA) since Mr Jesper Sentow B.Sc. (Econ) CPA MBA Mr Sentow joined the Board of LIWA in He operates his own management consultancy which specialises in corporate financial and strategic planning, restructuring and commercial improvements. He has spent over 20 years in senior financial management positions with a number of international and Australian companies including St John s Ambulance. Professor Grant Waterer MBBS FRACP Staff and UWA Representative Professor Waterer is a Professor of Medicine at UWA and Adjunct Associate Professor of Medicine at North-western University, Chicago. He is a consultant respiratory physician at Royal Perth Hospital and Head of the Infectious Diseases Unit of LIWA. He is currently the chair of the Respiratory Infectious Diseases Advisory Group for the Australian Lung Foundation, the co-chair of the American Thoracic Society Bronchiectasis Statement and clinical advisor to the Spanish Critical Care Network. He is on the editorial board of the leading pulmonary journal (the American Journal of Respiratory and Critical Care Medicine) as well as the leading spanish language respiratory journal (Medicina Respiratoria) and an associate editor for Respirology. He serves on international advisory boards for AstraZeneca, Bayer, GlaxoSmithKline and Pfizer. ABOUT LIWA BOARD MEMBERS 17
18 scientific subcommittee report Once again, the Scientific Subcommittee assessed applications for the LIWA PhD and Travel Awards. These awards support the Institute s objectives of promoting excellence in research in the area of lung disease, and providing support to medical scientists. The awards are open to applicants across Australia. The Scientific Subcommittee would like to congratulate the winners of the 2009 awards, including Ms Li Ping Chung (PhD Top Up Award), Dr Alexander Larcombe (Senior Scientist Travel Award), Ms Melanie Leffler and Ms Elizabeth Bozanich (Junior Scientist Travel Awards). ABOUT LIWA SCIENTIFIC SUBCOMMITTEE REPORT The members of the Scientific Subcommittee in 2009 were Professor Geoffrey Stewart (Chair), Professor Richard Ruffin, Professor D Arcy Holman, and Professor Michael Garlepp. Professor Steven Holgate from the University of Southampton, UK, continues to be the international corresponding member. The roles of the scientific subcommittee are to: advise the Board with respect to awarding grants and scholarships; assist the Board in determining the rules and regulations for grants and scholarships; assist the Board in finding eminent scientists to visit and / or contribute to the work of the Institute; provide advice to the Board via the Director of the Institute on the appropriateness of major expenditure on scientific equipment; and advise the Board via the Director on matters relating to scientific direction and the terms of reference for scientific reviews of the Institute. The Scientific Subcommittee also fulfils the role of the Institute s independent Research Committee. This committee takes responsibility for ensuring that research undertaken and funded by donations to the Institute is scientific in nature and that it is, or may prove to be of value, to Australia. Donations to the Institute are held in a specific research account and the Committee advises the Director and the LIWA Board on disbursement of funds from the account. The National Health and Medical Research Council (NHMRC) has approved the members of the Committee in terms of their proven ability to direct research programs as evidenced by their academic qualifications and professional appointments. Professor Geoffrey A Stewart Chair, Scientific Subcommittee Annual Report Lung Institute of Western Australia Inc.
19 education programs and initiatives LIWA continued to provide high quality educational events and opportunities to the medical and scientific community in Awards and Scholarships PhD Top Up Award Ms Li Ping Chung was awarded LIWA s PhD Top Up Award, giving her access to $8,500 per annum for three years or until submission of her thesis. Li Ping is working on the pharmacogenetics of beta 2 receptors and severe asthma. Senior Travel Award Dr Alexander Larcombe was awarded the 2009 Senior Travel Award, in recognition of his outstanding research into the effects of age of infection and sex on the acute consequences of influenza A infection at the Telethon Institute for Child Health Research (TICHR). The $3000 award allowed him to attend the American Thoracic Society (ATS) Annual International Conference in San Diego. At this conference he presented his work, attended an abundance of education sessions on advances in the field of respiratory physiology and enjoyed the opportunity to network with leaders in the respiratory community. Alexander was grateful for the opportunity to attend this meeting which would not have been possible without the assistance of the LIWA Travel Award. Junior Travel Awards LIWA recognises the need for junior scientists to attend national and international education events, and thus offers two awards per year to facilitate this. Miss Melanie Leffler and Ms Elizabeth Bozanich were awarded the Junior Medical Scientist Award of $1750 each in recognition of the excellent start that they have made in their scientific careers. Vacation Cadetships LIWA also provides a number of funded Vacation Cadetships to medicine or science undergraduate students who demonstrate exceptional talent in order to support their careers and provide experience in the research environment. Cadetships were awarded for 2009 to Ms Sarah Hayton, Mr Thomas Iosifidis, Ms Sai Baskar and Ms Sweeka Alexander. Honours Scholarships As a new addition to LIWA s scholarship and awards program during it s 10th Anniversary, we were pleased to offer the inaugural $5000 Honours Scholarships to Ms Kimberley Birnie and Ms Sarah Hayton. Education Events Medical Research Seminar Series LIWA also continued its long tradition of hosting a monthly Medical Research Seminar Series featuring high quality research conducted in Western Australia. The series of seminars helps expose clinicians and scientists to the latest advances in a diverse range of topics. ABOUT LIWA EDUCATION PROGRAMS AND INITIATIVES 19
20 ABOUT LIWA EDUCATION PROGRAMS AND INITIATIVES Presentations included the following: Professor George Yeoh (WAIMR): Liver progenitor cells Good cells or bad cells? Associate Professor Kevin Pfleger (WAIMR): Advances in the use of BRET to study G-Protein Coupled Receptor Complexes. Dr Ben Corry (UWA): Understanding ion channel selectivity and gating (and its application to the desalination of water). Dr Christopher Peacock (TICHR): The practical implications of pathogen sequencing in the genomic era. Professor Mike Daube (Curtin University): Tobacco control in Australia: why we are winning and where are the next frontiers? Ms Rachel Ramsdale (WAIMR): Molecular Discovery Systems: Western Australian Imaging and Analysis Technology, and Professor Simon Brown (RPH): Insect bites and stings: why they are so dangerous? Visiting lecturers Visiting speakers were also a highlight on the educational calendar, with Associate Professor Alaina Ammit from the University of Sydney as a visiting speaker in September. LIWA and the Raine Foundation co-hosted a presentation by Professor Richard Light of Vanderbilt University, USA in November th anniversary celebrations Lung and Biological Sciences Symposium LIWA s 10th Anniversary year began with a Lung and Biological Sciences Symposium on March at the University Club, Perth, Western Australia. The event was attended by local, national and international delegates, with world-leading scientists presenting on a range of topics from both scientific and clinical fields. The diversity of the meeting as well as the standard of presentations was outstanding and LIWA is proud to consider it as the most successful symposium of its kind that Perth has hosted. In conjunction with the Symposium, LIWA held a 10th Anniversary cocktail party at Matilda Bay Restaurant, Perth, to which all LIWA members, symposium presenters and staff were invited. The Board of LIWA was pleased to acknowledge a group of long standing members at this event, particularly those who had been members since LIWA s inception. These individuals are listed later in this report Annual Report Lung Institute of Western Australia Inc.